With the news that Vitalik Buterin and CZ jointly launched a DeSci platform in Bangkok, and Binance Labs invested in the DeSci fundraising platform Bio Protocol, the visibility of the DeSci field was also quickly opened up. Previously, Chain News also introduced the Bio Protocol ecosystem, taking readers to understand this field that some participants hailed as a new round of cyclical narratives. Recently, Mechanism Capital partner Andrew Kang even compared the current DeSci to the DeFi of 2019 on social media.

(What is DeSci famous for? BIO Protocol ecological guide for Vitalik and CZ synchronization platforms)

DeSci Dazai asks: Is it really better to hand over investment opportunities to retail investors?

First of all, let me review for you. Traditional scientific research and development is mainly carried out by consortia or government-funded scientists for continuous development. The concept of DeSci is to organize a DAO to raise funds to sponsor scientific development in specific fields. For example, HairDAO is focused on the development of preventing hair loss. Compared with traditional scientific development, this fundraising method seems to be more decentralized, turning the source of funds into crowdfunding, and returning successfully developed patents to the community.

However, there is a huge demand for funds for scientific development, and investors only provide funds to scientists after careful evaluation. Letting the masses become investors seems more decentralized, but it also raises a question: Do retail investors really understand what they are investing in? Or perhaps lowering the threshold for entry into this field will turn investment into speculation, with retail investors treating investment science as looking for the next target that will be worth a hundred or ten times in the secondary market.

Popular Partner: DeSci now is DeFi in 2019

Going back to Andrew Kang’s post, he said: “The current DeSci field feels like the DeFi era in early 2019. Everything is still primitive and experimental, but now the potential opportunities can be recognized, that is, there is huge potential. "

He then pointed out that the current project is likely to be a completely different model or product from the future, but that is because the evolution of the protocol is always developed through continuous iterations. This was the case with Maker, Synthetix, and Aave in 2019, which had minimal market cap or TVL at the time and are now large protocols. Finally, he also placed orders for three protocols including Bio Protocol, Pump Science and GLP1Science.

Later, he also revealed in the message area that he had participated in Bio Procotol’s latest round of financing, but Bio Protocol has not yet seen institutional-level financing outside of Binance. Therefore, Andrew is probably referring to the Genesis project, which is publicly funded by the community.

This article Venture Capital Publicly Calls for Single and Three Targets: DeSci now is DeFi in 2019, implying huge potential in the future. First appeared on Chain News ABMedia.